HUM Humana Inc.

A.M. Best Comments on Credit Ratings of Humana Inc. Following Decision by U.S. District Court

A.M. Best has commented that the under review with positive implications status and the Financial Strength Ratings, Long-Term Issuer Credit Ratings and Long- and Short-Term Issue Credit Ratings of Humana Inc. (Humana) (headquartered in Louisville, KY) [NYSE:HUM] and its subsidiaries remain unchanged.

This comment by A.M. Best follows the decision by the U.S. District Court for the District of Columbia to block Humana’s merger with Aetna Inc. (Aetna). If Aetna and Humana do not appeal the court’s decision, the Credit Ratings (ratings) will remain under review until A.M. Best assesses Humana’s 2016 year-end results and its 2017 financial and capital plans.

Should Aetna and Humana choose to appeal the court’s decision, the ratings of Humana will remain under review with positive implications while A.M. Best conducts discussions with Humana’s management regarding the appeal process and reviews its 2016 year-end results and 2017 financial and capital plans.

This press release relates to Credit Ratings that have been published on A.M. Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see A.M. Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Understanding Best’s Credit Ratings.

A.M. Best is the world’s oldest and most authoritative insurance rating and information source. For more information, visit www.ambest.com.

Copyright © 2017 by A.M. Best Rating Services, Inc. and/or its subsidiaries. ALL RIGHTS RESERVED.

EN
24/01/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Humana Inc.

Moody’s Ratings announces completion of a periodic review of ratings o...

New York , October 24, 2025 – Moody's Ratings (Moody's) has completed a periodic review of the ratings of Humana Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 22 October 2025 in which we reassessed the appropriateness of the ...

Jonathan Moreland
  • Jonathan Moreland

Monthly Insider Special Screens: June 1, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: May 17, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Humana Inc: 1 director

Two Directors at Humana Inc bought 7,133 shares at between 0.000USD and 229.247USD. The significance rating of the trade was 76/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch